(Q46575617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

C T Sauter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M M Panis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C S Biswas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T Budak-Alpdogan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Durham

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

N Flomenberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

O Alpdogan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

29 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1237-1242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624821%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2013.47

29 February 2020

exact match

0 references

cites work

Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

In vivo survival and homeostatic proliferation of natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

A potential role for interleukin-15 in the regulation of human natural killer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Determination of lymphocyte division by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Target-effector interaction in the natural killer cell system: isolation of target structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Safety and immunologic effects of IL-15 administration in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

IL-15 Mediates Anti-tumor Effects after Cyclophosphamide Injection of Tumor-Bearing Mice and Enhances Adoptive Immunotherapy: The Potential Role of NK Cell Subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

T cell homeostatic proliferation elicits effective antitumor autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.47

7 January 2021

https://api.fatcat.wiki/v0/release/l6iwek2ytncrrn4l2jce3sm6fm

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_l6iwek2ytncrrn4l2jce3sm6fm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l6iwek2ytncrrn4l2jce3sm6fm

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/l6iwek2ytncrrn4l2jce3sm6fm

30 July 2022